Lupus nephritis is a severe manifestation of SLE that results in end-stage renal disease.
WHO classification of Lupus Nephritis
| Class | Description | Nota bene |
|---|---|---|
| Class I | Normal kidneys | |
| Class II | Mesangial glomerulonephritis | Non-proliferative form |
| Class III | Focal and segmental proliferative glomerulonephritis | Proliferative form |
| Class IV | Diffuse proliferative glomerulonephritis | The most common and severe (proliferative) form. |
| Class V | Diffuse membranous glomerulonephritis | Non-proliferative form |
| Class VI | Sclerosing glomerulonephritis |
- Signs and symptoms
- Proteinuria
- Haematuria
- Pyuria
- Red blood cell casts
- Elevated serum creatinine
- Decreased GFR
- Hypetension
- Oedema (due to nephrotic-range proteinuria)
- Treatment
- Early identification is important
- Immunosuppressive therapy
- Corticosteroids
- Cyclophosphamide
- Mycophenolate
- Azathioprine
- Rituximab
- Blood presure control using ACEis or ARBs
- Statins if dyslipidaemia is present
- Hydroxychloroquine for all patients with SLE unless contraindicated
- Prophylaxis against infection and osteoporosis due to long-term immunosuppression or corticosteroids.